Evidence map›Paper›PMID 33750734›Full record

ArticleJournal of medical Internet research2021

Classification Models for COVID-19 Test Prioritization in Brazil: Machine Learning Approach.

Íris Viana Dos Santos Santana, Andressa Cm da Silveira, Álvaro Sobrinho, Lenardo Chaves E Silva, Leandro Dias da Silva, Danilo F S Santos, Edmar C Gurjão, Angelo Perkusich

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning.Interdisciplinary sciences, computational life sciences · 2022
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Íris Viana Dos Santos SantanaFederal University of the Agreste of Pernambuco, Garanhuns, Brazil.ORCID 0000-0001-9519-5039
Andressa Cm da SilveiraFederal University of Campina Grande, Campina Grande, Brazil.ORCID 0000-0002-7560-4488
Álvaro SobrinhoFederal University of the Agreste of Pernambuco, Garanhuns, Brazil.ORCID 0000-0002-1753-1890
Lenardo Chaves E SilvaFederal Rural University of the Semi-Arid, Pau dos Ferros, Brazil.ORCID 0000-0002-4509-8270
Leandro Dias da SilvaFederal University of Alagoas, Maceió, Brazil.ORCID 0000-0003-4352-1466
Danilo F S SantosFederal University of Campina Grande, Campina Grande, Brazil.ORCID 0000-0002-8162-715X
Edmar C GurjãoFederal University of Campina Grande, Campina Grande, Brazil.ORCID 0000-0001-9694-3668
Angelo PerkusichFederal University of Campina Grande, Campina Grande, Brazil.ORCID 0000-0002-7377-1258

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundControlling the COVID-19 outbreak in Brazil is a challenge due to the population's size and urban density, inefficient maintenance of social distancing and testing strategies, and limited availability of testing resources.

objectiveThe purpose of this study is to effectively prioritize patients who are symptomatic for testing to assist early COVID-19 detection in Brazil, addressing problems related to inefficient testing and control strategies.

methodsRaw data from 55,676 Brazilians were preprocessed, and the chi-square test was used to confirm the relevance of the following features: gender, health professional, fever, sore throat, dyspnea, olfactory disorders, cough, coryza, taste disorders, and headache. Classification models were implemented relying on preprocessed data sets; supervised learning; and the algorithms multilayer perceptron (MLP), gradient boosting machine (GBM), decision tree (DT), random forest (RF), extreme gradient boosting (XGBoost), k-nearest neighbors (KNN), support vector machine (SVM), and logistic regression (LR). The models' performances were analyzed using 10-fold cross-validation, classification metrics, and the Friedman and Nemenyi statistical tests. The permutation feature importance method was applied for ranking the features used by the classification models with the highest performances.

resultsGender, fever, and dyspnea were among the highest-ranked features used by the classification models. The comparative analysis presents MLP, GBM, DT, RF, XGBoost, and SVM as the highest performance models with similar results. KNN and LR were outperformed by the other algorithms. Applying the easy interpretability as an additional comparison criterion, the DT was considered the most suitable model.

conclusionsThe DT classification model can effectively (with a mean accuracy≥89.12%) assist COVID-19 test prioritization in Brazil. The model can be applied to recommend the prioritizing of a patient who is symptomatic for COVID-19 testing.

Indexed as

COVID-19COVID-19 TestingMachine LearningSARS-CoV-2BrazilHumansLogistic ModelsSupport Vector Machineclassification modelsCOVID-19medical diagnosistest prioritization

Identifiers

PMID33750734
PMCPMC8034680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.